VuCOMP receives FDA approval for M-Vu CAD for mammography version 3.1

[News]

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views.

More... (http://www.news-medical.net/news/20140610/VuCOMP-receives-FDA-approval-for-M-Vu-CAD-for-mammography-version-31.aspx)